Johnson & Johnson

Decennale USA in calo target 4% 20.11.23

121
Decennale USA prova a rompere al ribasso un testa e spalle dagli sviluppi importanti.
Analizziamo MRNA PFE BABA BMY JNJ

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.